Patents by Inventor Kevin John Lafferty

Kevin John Lafferty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of coxiella bacteria to treat autoimmune disease
    Patent number: 6790450
    Abstract: Therapeutic compositions including a species of Coxiella or one or more antigenic components therefrom or analogous or homologous components thereof are disclosed. These compositions are useful in preventing, inhibiting, delaying onset of or otherwise ameliorating the effects of an autoimmune disease in a mammal, particularly insulin-dependent diabetes mellitus (IDDM). They arm also useful in prolonging survival of islet tissue transplanted into a mammal.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: September 14, 2004
    Assignee: The Australian National University
    Inventors: William Butler Cowden, Kevin John Lafferty, Lawrence Scott Gazda
  • Use of Coxiella bacteria to treat autoimmune disease
    Publication number: 20040105867
    Abstract: Therapeutic compositions including a species of Coxiella or one or more antigenic components therefrom or analogous or homologous components thereof are disclosed. These compositions are useful in preventing, inhibiting, delaying onset of or otherwise ameliorating the effects of an autoimmune disease in a mammal, particularly insulin-dependent diabetes mellitus (IDDM). They are also useful in prolonging survival of islet tissue transplanted into a mammal.
    Type: Application
    Filed: November 10, 2003
    Publication date: June 3, 2004
    Applicant: The Australian National University
    Inventors: William Butler Cowden, Kevin John Lafferty, Lawrence Scott Gazda
  • Use of coxiella bacteria to treat autoimmune disease
    Publication number: 20010051162
    Abstract: Therapeutic compositions including a species of Coxiella or one or more antigenic components therefrom or analogous or homologous components thereof are disclosed. These compositions are useful in preventing, inhibiting, delaying onset of or otherwise ameliorating the effects of an autoimmune disease in a mammal, particularly insulin-dependent diabetes mellitus (IDDM). They are also useful in prolonging survival of islet tissue transplanted into a mammal.
    Type: Application
    Filed: June 21, 2001
    Publication date: December 13, 2001
    Inventors: William Butler Cowden, Kevin John Lafferty, Lawrence Scott Gazda